When evaluating DNA evidence within a likelihood ratio framework, should the propositions be exhaustive?


Journal

Forensic science international. Genetics
ISSN: 1878-0326
Titre abrégé: Forensic Sci Int Genet
Pays: Netherlands
ID NLM: 101317016

Informations de publication

Date de publication:
01 2021
Historique:
received: 06 04 2020
revised: 21 09 2020
accepted: 03 10 2020
pubmed: 4 11 2020
medline: 6 7 2021
entrez: 3 11 2020
Statut: ppublish

Résumé

We seek to develop a rational approach to forming propositions when little information is available from the outset, as this often happens in casework. If propositions used when evaluating evidence are not exhaustive (in the context of the case), then there is a theoretical risk that an LR greater than one may be associated with a proposition in the numerator that - if all meaningful propositions had been considered - would in fact have a lower posterior probability after consideration of the evidence. Ideally, all propositions should be considered. However, with multiple propositions, some terms will be larger than others and for simplification very small terms can be neglected without changing the order of magnitude of the value of the evidence (i.e. LR). Our analysis shows that mathematically a contributor's DNA can be assumed to be present under both prosecution and alternative propositions (H

Identifiants

pubmed: 33142191
pii: S1872-4973(20)30178-2
doi: 10.1016/j.fsigen.2020.102406
pii:
doi:

Substances chimiques

DNA 9007-49-2

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

102406

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

John Buckleton (J)

Institute of Environmental Science and Research Limited, Private Bag 92021, Auckland, 1142, New Zealand; University of Auckland, Department of Statistics, Auckland, New Zealand. Electronic address: john.buckleton@esr.cri.nz.

Duncan Taylor (D)

Forensic Science SA, 21 Divett Place, Adelaide, SA, 5000, Australia; School of Biological Sciences, Flinders University, GPO Box 2100, Adelaide, SA, 5001, Australia.

Jo-Anne Bright (JA)

Institute of Environmental Science and Research Limited, Private Bag 92021, Auckland, 1142, New Zealand.

Tacha Hicks (T)

Forensic Genetics Unit, University Center of Legal Medicine, Lausanne - Geneva, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; Fondation pour la formation continue Universitaire Lausannoise (UNIL-EPFL), 1015, Dorigny, Switzerland.

James Curran (J)

University of Auckland, Department of Statistics, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH